- Total raised
- $157.8M
- Stage
- Series C
- Team size
- 51-200 employees
- Founded
- 2013
- HQ
- Cambridge
About Nuclera
Nuclera offers a protein prototyping system to accelerate drug discovery by making proteins readily available to researchers.
Open roles · 2
Location
More startups in Cambridge
Suno
Cambridge
Suno turns ideas into songs, a music company founded by Harvard alumni. Valued at $2.45B after $400M raise, with $200M in subscription revenue, 150 bandmates, and offices in Boston/Cambridge, Venice Beach, San Francisco, and NYC; 100M+ have
CuspAI
Cambridge
CuspAI is an AI company that discovers new materials to solve problems and enable human progress.
Merida Biosciences
Cambridge
Merida Biosciences is a biotechnology company pioneering a new class of precision therapeutics designed to selectively and durably eliminate pathogenic antibodies that drive disease.
Maxion Therapeutics
Cambridge
Ion channel and GPCR drug discovery using innovative KnotBody technology
Bindbridge
Cambridge
AI-based molecular glue discovery for sustainable agriculture.
Constructive Bio
Cambridge
At Constructive Bio we rewrite genomes to build the biomolecules of the future.